Publications

5674 Results

Chemotherapy versus chemotherapy plus radio- therapy for Stage IIIA, IIIB Hodgkin's disease. A Southwest Oncology Group (SWOG) study

Authors
EJ DePersio;PN Grozea;R Fisher;SE Jones;CA Coltman Jr
Journal / Conference
Proceedings of American Society of Therapeutic Radiologists #110
Year
1979
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7518

Treatment of refractory lymphoma with vincristine, BCNU, Adriamycin, and Prednisone (VBAP)

Authors
J Weick;S Jones
Journal / Conference
ASCO #C-266
Year
1979
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7707

Primary therapy of Stage III & IV diffuse Non-Hodgkin's Lymphoma with combination chemotherapy, total body irradiation

Authors
J Weick;A Antunez;C Fabian
Journal / Conference
AACR 20:145 (#583)
Year
1979
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7761

Phase II trial of Dianhydrogalactitol in metastatic malignant melanoma. A Southwest Oncology Group study.

Authors
JT Thigpen;M Al-Sarraf;JS Hewlett
Journal / Conference
Cancer Treat Rep 63(4):525-528
Year
1979
Research Committee(s)
Melanoma
Study Number(s)
SWOG-7520

Chemoimmunotherapy for disseminated melanoma.

Authors
J Costanzi;M Al-Sarraf;D Dixon
Journal / Conference
ASCO, #C-293
Year
1979
Research Committee(s)
Melanoma
Study Number(s)
SWOG-7424/7425

The clinical trial of Cis-Platinum hydration with and without Mannitol in patients with previously treated advanced malignant melanoma.

Authors
M Al-Sarraf
Journal / Conference
AACR, #746
Year
1979
Research Committee(s)
Melanoma
Study Number(s)
SWOG-7730

Baker's Antifol (BAF) in combination with Methyl-CCNU and 5-FU after the treatment of metastatic colorectal cancer.

Authors
MT Shaw;LK Heilbrun
Journal / Conference
ASCO, #C-33
Year
1979
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-7764

Non-Cross resistant combination chemotherapy improves survival in multiple myeloma.

Authors
S Salmon;R Alexanian;D Dixon
Journal / Conference
Blood 54:207a (#552)
Year
1979
Research Committee(s)
Myeloma
Study Number(s)
SWOG-7704/05

ICRF-159 (razoxane) in the treatment of pediatric solid tumors: a Southwest Oncology Group study.

Authors
PG Dyment;KA Starling;VJ Land;A Cangir;DM Komp;CL Sexauer
Journal / Conference
Cancer Treat Rep 63(8):1397-1398
Year
1979

Weekly administrations of cis-platinum in childhood solid tumors. A Southwest Oncology Group study.

Authors
R Nitschke;R Fagundo;DH Berry;JM Falletta
Journal / Conference
Cancer Treat Rep 63(3):497-499
Year
1979